Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
The Roles of Micro- and Nanoscale Materials in Cell-Engineering Systems.
Jiang Y, Harberts J, Assadi A, Chen Y, Spatz JP, Duan W, Nisbet DR, Voelcker NH, Elnathan R. Jiang Y, et al. Adv Mater. 2024 Nov;36(48):e2410908. doi: 10.1002/adma.202410908. Epub 2024 Oct 14. Adv Mater. 2024. PMID: 39401098 Review.
Micro- and nanoscale-engineered materials are increasingly used to control core cell-level functions in cellular engineering. By reprogramming or redirecting targeted cells for extremely precise functions, these advanced materials offer new possibilities. ...The cur …
Micro- and nanoscale-engineered materials are increasingly used to control core cell-level functions in cellular engineering. By repr …
Engineering Efficient CAR-T Cells via Electroactive Nanoinjection.
Shokouhi AR, Chen Y, Yoh HZ, Brenker J, Alan T, Murayama T, Suu K, Morikawa Y, Voelcker NH, Elnathan R. Shokouhi AR, et al. Adv Mater. 2023 Nov;35(44):e2304122. doi: 10.1002/adma.202304122. Epub 2023 Sep 13. Adv Mater. 2023. PMID: 37434421
Chimeric antigen receptor (CAR)-T cell therapy has emerged as a promising cell-based immunotherapy approach for treating blood disorders and cancers, but genetically engineering CAR-T cells is challenging due to primary T cells' sensitivity to conventi …
Chimeric antigen receptor (CAR)-T cell therapy has emerged as a promising cell-based immunotherapy approach for treating blood …